Chingsong Health: April 2026 Monthly Revenue NT$106 Million (YoY +12.7%)
NQ Score
0/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Taiwanese biotechnology and medical company Chingsong Health announced its April 2026 monthly revenue reached NT$106 million, a 12.7% increase year-on-year, indicating stable growth in the biotechnology and medical market.